Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064493
Filing Date
2025-05-06
Accepted
2025-05-06 16:15:22
Documents
53
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20250331.htm   iXBRL 10-Q 1165332
2 EX-31.1 cycn-ex31_1.htm EX-31.1 13024
3 EX-31.2 cycn-ex31_2.htm EX-31.2 13027
4 EX-32.1 cycn-ex32_1.htm EX-32.1 7411
5 EX-32.2 cycn-ex32_2.htm EX-32.2 7414
  Complete submission text file 0000950170-25-064493.txt   5395155

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cycn-20250331.xsd EX-101.SCH 1109325
55 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20250331_htm.xml XML 716225
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 25917454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)